In just over four years, the Weill Cornell Medical Center Clinical and Translational Science Center (CTSC)has established a strong and highly effective clinical and translational science infrastructure spanning sixdiverse partners, each a center of excellence: Memorial Sloan-Kettering Cancer Center; Hospital for SpecialSurgery; Hunter College School of Nursing. Hunter College Gene Center-a Research Center for MinorityInstitutions (RCMI); Cornell University Cooperative Extension; and Cornell University, Ithaca. The mission ofthe CTSC in continuation is to leverage the resources and expertise of this rich multi-institutional partnershipto create new interdisciplinary teams and support cutting-edge research from bench to bedside to communityto health care practice. The proposed grant adds a new partner, the Animal Medical Center a few blocksfrom WCMC, to increase collaboration with Cornell University College of Veterinary Medicine. Jointly, theybring a new dimension to our CTSC research and their expertise in small animals will enhance pre-clinicalresearch in the area of drug discovery and device development.Built on the accomplishments achieved during the initial funding period, the strategic plans for the next fiveyears are geared to rapidly advance translational science discoveries by: 1) Enhancing the Drug DiscoveryPipeline; 2) Increasing the Breadth of Research Resources; 3) Adding New Expertise and TrainingPrograms; and 4) Enhancing Community Engagement and Dissemination. Moving forward, the anticipatedbenefits of fostering 'Innovation through Collaboration' during the next funding period include: 1) Furthergeneration of novel ideas leading to drug development and medical devices which benefit patient care; 2)Increased collaborative efforts with partners and industry, to facilitate research to improve the general healthofthe public; 3) Enhanced clinical translational (C/T) educational programs in comparative effectivenessresearch, global health and health information technology; 4) Enhanced community engagement; 5)Increased centralization of C/T research, education, infrastructure, and databases; and 6) Enhancedevaluation and tracking of CTSC programs.

Public Health Relevance

The broad research support infrastructure ofthe CTSC and its programs to foster interactions among basicscientists, clinicians and community practitioners are key to the rapid translation of basic science discoveriesinto effective clinical practice. Our CTSC is distinct in the heterogeneity of its component institutions,providing unparalleled opportunities for collaboration and training in all areas of biomedical sciences.PROJECT/RERFORMANCE SITE(S) (if additional space is needed, use

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
2UL1TR000457-06
Application #
8467203
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Sufian, Meryl
Project Start
2007-09-17
Project End
2017-05-31
Budget Start
2012-06-27
Budget End
2013-05-31
Support Year
6
Fiscal Year
2012
Total Cost
$9,406,232
Indirect Cost
$1,838,395
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Busch, Fredric N; Milrod, Barbara L (2018) Trauma-Focused Psychodynamic Psychotherapy. Psychiatr Clin North Am 41:277-287
Pianko, Matthew J; Moskowitz, Alison J; Lesokhin, Alexander M (2018) Immunotherapy of Lymphoma and Myeloma: Facts and Hopes. Clin Cancer Res 24:1002-1010
Trevino, Kelly M; Healy, Charlotte; Martin, Peter et al. (2018) Improving implementation of psychological interventions to older adult patients with cancer: Convening older adults, caregivers, providers, researchers. J Geriatr Oncol 9:423-429
Schelke, Matthew W; Attia, Peter; Palenchar, Daniel J et al. (2018) Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention. Front Aging Neurosci 10:96
Fox, Robert J; Coffey, Christopher S; Conwit, Robin et al. (2018) Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. N Engl J Med 379:846-855
Tsevat, Rebecca K; Radecki Breitkopf, Carmen; Landers, Sara E et al. (2018) Adolescents' and Parents' Attitudes Toward Adolescent Clinical Trial Participation: Changes Over One Year. J Empir Res Hum Res Ethics 13:383-390
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119
Pak, Linda M; Schattner, Mark A; Balachandran, Vinod et al. (2018) The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. HPB (Oxford) 20:182-187
Erkan, D; Unlu, O; Sciascia, S et al. (2018) Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. Lupus 27:399-406
Laird, James; Ma, Jennifer; Chau, Karen et al. (2018) Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement. Int J Radiat Oncol Biol Phys 100:670-678

Showing the most recent 10 out of 756 publications